Market cap
$340 Mln
Revenue (TTM)
$250 Mln
P/E Ratio
--
P/B Ratio
3.7
Div. Yield
0 %
| Edgio Inc (EGIO) | Envestnet (ENV) | Trxade Group Inc (MEDS) | |
|---|---|---|---|
Market cap ($ Mln) |
340 | 3,495 | 4 |
Revenue ($ Mln) |
250 | 1,337 | 8 |
Net Profit ($ Mln) |
-51.13 | -183,249.35 | -88.28 |
Net Margin (%) |
-20.61 | -13,708.02 | -1,100.30 |
RoE (%) |
-24.97 | -33,091.46 | -- |
Price to Earnings |
-- | -- | -- |
Price-To-Book |
3.74 | 6.64 | 1.81 |
Income Statement ($ Mln)
| Edgio Inc (EGIO) | Envestnet (ENV) | Trxade Group Inc (MEDS) | |
|---|---|---|---|
|
Operating Revenue
|
250.36 | 1,186.52 | 9.89 |
|
Cost of Revenue
|
171.80 | 423.72 | 5.14 |
|
Gross Profit
|
60.35 | 762.79 | 4.75 |
|
Operating Expenses
|
109.74 | 722.25 | 8.81 |
|
Operating Profit (EBIT)
|
-62.39 | 40.54 | -5.29 |
|
Other Income
|
-2.20 | -3.25 | -- |
|
Profit before Tax
|
-69.87 | 20.36 | -5.32 |
|
Provision for Tax
|
-18.74 | 7.67 | -1.20 |
|
Profit after Tax (Net Income)
|
-51.13 | 13.30 | -4.11 |
|
Minority Interest
|
0.00 | 2.45 | -- |
|
Consolidated Profit
|
-53.44 | 13.30 | -5.32 |
Liabilities ($ Mln)
| Edgio Inc (EGIO) | Envestnet (ENV) | Trxade Group Inc (MEDS) | |
|---|---|---|---|
|
Shareholder's Funds
|
336.61 | 957.09 | 3.77 |
|
Minority Interest
|
0.00 | 2.45 | -- |
|
Non-Current Liabilities
|
135.90 | 992.92 | 1.07 |
|
Current Liabilities
|
105.00 | 288.72 | 0.93 |
|
Total Liabilities
|
311.10 | 2,241.18 | 5.77 |
Assets ($ Mln)
| Edgio Inc (EGIO) | Envestnet (ENV) | Trxade Group Inc (MEDS) | |
|---|---|---|---|
|
Non-Current Assets
|
359.57 | 1,673.91 | 1.39 |
|
Current Assets
|
217.94 | 567.28 | 4.37 |
|
Total Assets
|
311.10 | 2,241.18 | 5.77 |
|
Total Debt*
|
138.31 | 965.78 | 1.25 |
|
Net Current Assets
|
112.95 | 278.55 | 3.45 |
Cashflow ($ Mln)
| Edgio Inc (EGIO) | Envestnet (ENV) | Trxade Group Inc (MEDS) | |
|---|---|---|---|
|
Cash From Operating Activities
|
0.01 | 250.58 | -2.57 |
|
Cash Flow from Investing Activities
|
-8.85 | -176.14 | -0.02 |
|
Cash from Financing Activities
|
4.53 | -29.17 | -0.21 |
|
Net Cash Inflow / Outflow
|
-4.88 | 45.27 | 3.05 |
Ratios
Profitability Ratios
| Edgio Inc (EGIO) | Envestnet (ENV) | Trxade Group Inc (MEDS) | |
|---|---|---|---|
|
ROCE (%)
|
-19.79 | 0.70 | -57.42 |
|
ROE (%)
|
-24.97 | 1.38 | -66.08 |
|
ROA (%)
|
-10.12 | 0.61 | -52.87 |
|
EBIT Margin (%)
|
-25.80 | -- | -- |
|
Net Margin (%)
|
-20.61 | 1.12 | -41.59 |
|
Cash Profit Margin (%)
|
0.00 | -- | -- |
Growth Ratios
| Edgio Inc (EGIO) | Envestnet (ENV) | Trxade Group Inc (MEDS) | |
|---|---|---|---|
|
Revenue Growth (%)
|
16.89 | 0.19 | -0.42 |
|
EBIT Growth (%)
|
-46.02 | -- | -- |
|
Net Profit Growth (%)
|
0.75 | 602.87 | -60.33 |
|
EPS Growth (%)
|
-- | 6.13 | -- |
|
Book Value Growth (%)
|
-- | -- | -- |
Valuation Ratios
| Edgio Inc (EGIO) | Envestnet (ENV) | Trxade Group Inc (MEDS) | |
|---|---|---|---|
|
Price / Earnings
|
-- | 326.28 | -- |
|
Price / Book Value
|
-- | 4.53 | -- |
|
Dividend Yield (%)
|
-- | -- | -- |
|
EV/EBITDA
|
-2.34 | 31.44 | 0.36 |
|
Market Cap ($ Cr)
|
-- | -- | -- |
Solvency Ratios
| Edgio Inc (EGIO) | Envestnet (ENV) | Trxade Group Inc (MEDS) | |
|---|---|---|---|
|
Debt to Equity
|
0.36 | 1.01 | 0.33 |
|
Short term debt to equity ratio
|
0.01 | 0.02 | 0.09 |
|
Current Ratio
|
2.08 | 1.96 | 4.72 |
|
Quick Ratio
|
2.08 | 1.96 | 4.66 |
|
Interest Coverage
|
-12.23 | 3.76 | -224.34 |
Operating Efficiency Ratios
| Edgio Inc (EGIO) | Envestnet (ENV) | Trxade Group Inc (MEDS) | |
|---|---|---|---|
|
Debtors to sales (%)
|
45.97 | 8.03 | 9.90 |
|
Asset Turnover
|
0.50 | 0.54 | 1.27 |
|
Receivable days
|
69.81 | 26.99 | 53.03 |
|
Inventory Days
|
-- | 0.00 | 46.66 |
|
Payable days
|
18.83 | 15.99 | 26.06 |
|
Cash Conversion Cycle
|
-- | 11.00 | 73.63 |